Editorial: harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with kmt2a (mll)-gene rearrangements

HIGHLIGHTS

• who: . and collaborators from the Universitu00e9 catholique de LouvainSchool of Life and Health Science, University of Roehampton, London, United Kingdom, Division of have published the article: Editorial: Harnessing chemotherapy resistance and development of novel therapeutic strategies for acute leukemia with KMT2A (MLL)-gene rearrangements, in the Journal: (JOURNAL)
• what: The study focused on leukemia with KMT2A::MLLT3, the most common KMT2A-fusion gene in AML, or with the high-risk KMT2A::AFDN fusion.
• how: This review discusses the pre-clinical results obtained with a wide range of FDA approved drugs which have been . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.